Cilostazol Tablet
Product Images NDC 63629-8795

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cilostazol (NDC 63629-8795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Cilostazol (Image 1)

Chemical structure diagram of the active ingredient Cilostazol, showing its molecular framework and functional groups as typically depicted in pharmaceutical labeling.*

FDA Label Image

Figure1 (Image 2)

A line graph depicting plasma concentration (ng/mL) over time (hours) for Cilostazol and its metabolites 3,4-dehydrocilostazol and 4'-trans-hydroxycilostazol. The graph shows three lines representing the concentration changes of each compound from 0 to 24 hours post-dose.*

FDA Label Image

Figure 2 (Image 3)

A bar chart showing percent mean improvement in maximal walking distance across eight clinical trials comparing placebo and cilostazol at 50 mg b.i.d. and 100 mg b.i.d. Dosage groups demonstrate varying improvements with the 100 mg dose consistently showing higher percent improvements. The trials vary in sample size (N) and duration, detailed below each trial number on the x-axis, with percent improvement on the y-axis.*

FDA Label Image

Label (Lbl636298795)

Label for Cilostazol Tablets USP, 100 mg oral tablets by Bryant Ranch Prepack. The label shows the NDC 63629-8795-1 and indicates a package size of 60 tablets. It includes storage instructions, dosage information, a barcode, and the BRP Pharmaceuticals logo with a note for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.